Continuum of Care in Recovery
ISSUP Botswana present their Webinar on Continuum of Care in Recovery.
All Resources for 'Medical, Clinical & Healthcare Services'
Réduire la stigmatisation à l’égard des personnes vivant avec le VIH et des personnes qui s’injectent des drogues
Malgré de nombreuses données probantes sur les effets négatifs de la stigmatisation vécue par les personnes vivant avec le VIH (PVVIH) et les personnes qui s’injectent des drogues dans les établissements de soins de santé, il existe...
Accounts of women identified as drinking at ‘high risk’ during pregnancy
Drinking alcohol during pregnancy is associated with Foetal Alcohol Spectrum Disorders (FASD), and women who drink at higher levels are more likely to have a baby with FASD.
Efforts to better understand and respond to ‘high risk’ drinking...
Webinaire sur la prévention de la toxicomanie chez les jeunes
L’International Society of Substance Use Professionals (ISSUP) Indonesia et l’Indonesia International Training and Treatment Centre (ITTC) ont organisé ensemble le deuxième webinaire sur la « Prévention de la toxicomanie chez les jeunes »...
Indonesia's INEP Plus Online Training
ISSUP Indonesia organized the Introduction to Evidence-Based Prevention (INEP) Online Course as a national-level training in Indonesia with 17 participants. The training, conducted by Dr.dr. Kristiana Siste, SpKJ, and Dr. Elvina K...
Treatment for drug and alcohol misuse should involve families and communities
Alcohol and other drug treatment are generally only provided for individuals, often away from their families. Treatment aims to improve well-being and reduce the harms of substance use and families and communities can play a significant...
PMGR: Recovery Kentucky: A Successful Model of Addressing Substance Use Disorder
The May 2023 Preventive Medicine Grand Rounds (PMGR) features Recovery Kentucky, a social model program that provides housing and recovery services for rural Kentuckians dealing with substance use disorder. The program is led by the...
La FDA approuve une nouvelle option de traitement à la buprénorphine pour le trouble lié à l’utilisation d’opioïdes
Pour diffusion immédiate : 24 mai 2023
Aujourd’hui, la Food and Drug Administration (FDA) des États-Unis a approuvé l’injection sous-cutanée à libération prolongée de Brixadi (buprénorphine) pour traiter les troubles modérés à graves liés...
FDA Approves New Buprenorphine Treatment Option for Opioid Use Disorder
For Immediate Release: May 23, 2023
Today, the U.S. Food and Drug Administration approved Brixadi (buprenorphine) extended-release injection for subcutaneous use (under the skin) to treat moderate to severe opioid use disorder (OUD)...
Covering Substance Use and Addiction Responsibly
Stories about substance use and addiction can be among the thorniest that health and science reporters encounter. This topic carries a long history of marginalizing the people most directly affected. In addition, deeply ingrained societal misconceptions about substance use make it difficult to separate fact from fiction
